HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

AbstractBACKGROUND:
Hypoxia is a hallmark of solid cancers, including hepatocellular carcinoma (HCC). There is scarce information about how hypoxia avoids immunologic stress and maintains a cancer-promoting microenvironment.
METHODS:
The Cancer Genome Atlas, RNA-seq data, and Oncomine database were used to discover the correlation of RNASEH2A with tumor progression; then expression of RNASEH2A mRNA and protein were detected in HCC tissues and cells subjected to hypoxia or with the treatment of CoCl2 via real-time quantitative polymerase chain reaction and immunochemistry assays. Finally, the effect of RNASEH2A on cell proliferation and the involved signaling pathway was explored further.
RESULTS:
RNASEH2A was positively correlated with tumor grade, size, vascular invasion, and poor prognosis. The expression of RNASEH2A mRNA and protein were increased and dependent on hypoxia-inducible factor 2α in HCC tissues and cell lines. Knockout of RNASEH2A in HCC cells greatly reduced cell proliferation and induced the transcription of multiple cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes) targeted type 1 interferon-related genes, including IFIT1, USP18, and CXCL10, which suggests knockout of RNASEH2A may produce immunologic stress and tumor suppressive effects.
CONCLUSIONS:
RNASEH2A plays a critical role and potentially predicts patient outcomes in HCC, which uncovers a new mechanism that RNASEH2A contributes to limit immunologic stress of cancer cells in the context of hypoxia.
AuthorsFengbo Zhao, Aifen Liu, Xiu Gong, Hao Chen, Jinhuan Wei, Bin Chen, Shiyin Chen, Riyun Yang, Yihui Fan, Renfang Mao
JournalTumori (Tumori) Vol. 108 Issue 1 Pg. 63-76 (Feb 2022) ISSN: 2038-2529 [Electronic] United States
PMID34165025 (Publication Type: Journal Article)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • CXCL10 protein, human
  • Chemokine CXCL10
  • IFIT1 protein, human
  • Membrane Proteins
  • RNA-Binding Proteins
  • STING1 protein, human
  • Nucleotidyltransferases
  • cGAS protein, human
  • ribonuclease HII
  • Ribonuclease H
  • USP18 protein, human
  • Ubiquitin Thiolesterase
Topics
  • Adaptor Proteins, Signal Transducing (genetics)
  • Carcinoma, Hepatocellular (genetics, immunology, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (genetics)
  • Chemokine CXCL10 (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (immunology)
  • Gene Knockout Techniques
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms (genetics, immunology, pathology)
  • Male
  • Membrane Proteins (genetics)
  • Nucleotidyltransferases (genetics)
  • Prognosis
  • RNA-Binding Proteins (genetics)
  • Ribonuclease H (genetics)
  • Signal Transduction (genetics)
  • Tumor Hypoxia (genetics)
  • Tumor Microenvironment (immunology)
  • Ubiquitin Thiolesterase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: